Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
SGLT2 inhibitors (SGLT2i) have lately gained popularity as an effective treatment for type 2 diabetes (T2D), with additional benefits due to well-known large trials showing cardiovascular and kidney protection, especially in patients with established chronic kidney disease and heart failure. While SGLT2i have been shown to be effective for treating T2D, there have been concerns about their potential risks, including the risk of cancer.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.